Cargando…
The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis
Considering the easy contagion of tuberculosis (TB) disease spread and the emergence of multidrug-resistant TB, which directly impacts the failure of therapeutic goals and mortality rates increasing, TB disease control remains to be the main concern of continuous health development effort. Therefore...
Autores principales: | Kusuma, Sri Agung Fitri, Iskandar, Yoppi, Dewanti, Mutiara Ayu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801586/ https://www.ncbi.nlm.nih.gov/pubmed/29441323 http://dx.doi.org/10.4103/japtr.JAPTR_283_17 |
Ejemplares similares
-
In vitro embryotoxicity and mode of antibacterial mechanistic study of gold and copper nanoparticles synthesized from Angelica keiskei (Miq.) Koidz. leaves extract
por: Krishnaraj, Chandran, et al.
Publicado: (2022) -
A Chalcone from Ashitaba (Angelica keiskei) Stimulates Myoblast Differentiation and Inhibits Dexamethasone-Induced Muscle Atrophy
por: Kweon, Minson, et al.
Publicado: (2019) -
Inhibition of plasminogen activator inhibitor-1 release from human endothelial cells by Angelica keiskei Koidzumi (Ashitaba) chalcones is structure-dependent
por: Ohkura, Naoki, et al.
Publicado: (2015) -
Angelica keiskei (Ashitaba) powder and its functional compound xanthoangelol prevent heat stress-induced impairment in sperm density and quality in mouse
testes
por: KOKUBU, Daichi, et al.
Publicado: (2019) -
Inhibitory activity of xanthoangelol isolated from Ashitaba (Angelica keiskei Koidzumi) towards α-glucosidase and dipeptidyl peptidase-IV: in silico and in vitro studies
por: Aulifa, Diah Lia, et al.
Publicado: (2022)